EPISODE #68 European Cannabis - A Dutch View with Tjalling Erkelens, Co-Founder and CEO of Bedrocan - a podcast by Anuj Desai

This episode was recorded at the Central European Cannabis Forum where we were joined by Tjalling Erkelens, Co-Founder and CEO of Bedrocan, who are exclusive suppliers of medical cannabis to the Dutch Government.

We examine attitudes towards CBD, medical, and recreational cannabis in The Netherlands, alongside discussing the importance of consistency and standardisation of medical cannabis.

View full show notes and summary here: https://www.cannabis-conversation.com/blogs/episode68

About Tjalling
Tjalling Erkelens is the founder of Bedrocan and currently holds the position of CEO. He started Bedrocan in the Netherlands as a family business, and he maintains these roots as Bedrocan continues to grow. 

Since 2003 Bedrocan provides standardised cannabis of pharmaceutical quality to the Dutch government. It’s the oldest legal company in the world providing several, chemically different cannabis varieties to be used by patients on doctor’s prescription and as a raw material for the pharmaceutical industry (API).

For the past 20 years, Tjalling has developed and standardised unique methods of producing cannabis to pharmaceutical standards to a level achieved by no other company.

His strong commitment to product quality resulted in the Dutch Bedrocan production facilities being approved for GMP (good manufacturing practice) by the Dutch Health Authorities in 2017.

It is Erkelens’ strong belief that there should be a clear distinction between medicinal and recreational use of cannabis and that patient needs for safe and consistent cannabis is a priority. He is convinced that this can be achieved by going through the official drug approval process. “Fully standardised medicinal cannabis is the foundation on which such approval can be achieved.

Further episodes of The Cannabis Conversation | Medical Cannabis | CBD | Hemp

Further podcasts by Anuj Desai

Website of Anuj Desai